Vincent Thomas, Ph.D., is joining Lallemand Health Solutions as R&D Innovation Director. Mr. Thomas will start his new position on December 5…
Lallemand Health Solutions team will be at the Food ingredients (Fi) Europe, co-hosted with Health ingredients (Hi) Europe, from December 6 to…
Lallemand Health Solutions will be presenting its nutricosmetics innovations at Cosmetic 360®, the international innovation fair for cosmetic and perfume industry held…
Lallemand Health Solutions is joining forces with the French Gut Project, which aims to collect 100,000 French intestinal metagenomes for analysis, and…
For the first time a health authority recognizes that probiotics, particularly Lallemand Health Solutions strains Bifidobacteria infantis Rosell®-33, and Bifidobacteria bifidum Rosell®-71,…
Lallemand Health Solutions inaugurated its ultra-modern probiotic bacteria production plant, Harmonium II, with elected officials from the Mirabel region, Ms. Sylvie D’Amours,…
The Rosell® Institute for Microbiome and Probiotics by Lallemand reconducts its platinum sponsorship of the Canadian microbiome symposium, Having IMPACTT, for a…
As Gold Sponsor, Lallemand Health Solutions is supporting the IPA World Congress + Probiota Americas, presented by NUTRAIngredients-USA.com. This major annual event…
Sara Caballero Calero, M.Sc. Clinical Research Specialist at the Rosell® Institute from Microbiome and Probiotics by Lallemand, will be the guest speaker…
Lallemand Health Solutions has gained innovative indications for its probiotic strain L. rhamnosus HA-114 from Health Canada, recognizing its beneficial impact to…
